Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
Carly St. Germain(Ottawa Hospital), Jim Dimitroulakos(Ottawa Hospital Research Institute)
Cited by 24
Related Papers
Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
|PLoS ONE|2012|48
Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
|PLoS ONE|2010|32
Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer
|Translational Oncology|2018|31
Lovastatin‐induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal
|International Journal of Cancer|2013|25